Real-World Evidence Supports Effectiveness of First-line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer – Yahoo Finance

CONTEXT:  Peer reviewed publication of a large scale retrospective study in metastatic breast cancer, published in “Breast Cancer Research” journal.  Outcomes from th study underline the value of RWE in Continue Reading

Posted On :